跳至主要内容
临床试验/JPRN-UMIN000004298
JPRN-UMIN000004298招募中未知

Developing molecular markers to select the anti-cancer therapies in metastatic colorectal cancer - Molecular markers to select the anti-cancer therapies in metastatic colorectal cancer

Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University0 个研究点目标入组 150 人开始时间: 2010年9月30日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients without informed consent. 2. Formalin-fixed, paraffin-embedded (FFPE) samples of tumor tissue are not available

研究者

发起方
Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University

相似试验

招募中
Unknown
Identification of the molecular basis of anti-cancer effect of Huaier.Cancers such as hepatocellular carcinoma, breast cancer, colorectal cancer and related gastrointestinal cancers, urologic cancers including prostate cancer, pancreas cancer, and lung cancer), on which a significant therapeutic efficacy of Huaier has been reported. Special remarks is emphasized on the cancer cases designated to be related to cancer stem cells.
JPRN-jRCT1091220335Manami Tanaka, M.D., Ph.D., Bradeion Institute of Medical Sciences, Co. Ltd.80
招募中
不适用
Development of molecular diagnostic markers using oral fluid for diagnosis of periodontitis in diabetesDiseases of the musculo-skeletal system and connective tissue
KCT0001023Asan Medical Center24
招募中
不适用
Biobank for development of screening markers for colorectal neoplasia. Translational research in colorectal cancer and adenomas.Coloncancer. Large polyps.10017990
NL-OMON37786Vrije Universiteit Medisch Centrum3,500
招募中
不适用
Molecular markers for diagnosis and therapy response in Inflammatory Bowel diseases: A prospective population based bio-bank of inflammatory bowel disease patients in Zuid Limburg, The Netherlands.inflammatory bowel disease10017969
NL-OMON50587Interne geneeskunde/Divisie MD5,000
招募中
不适用
Evaluation of molecular markers to predict the pattern of tumor recurrence and prognosis in pancreatric ductal adenocarcinomaC25Malignant neoplasm of pancreas
DRKS00006179Klinik und Poliklinik für Allgemein-, Viszeral-, Tumor- und Transplantationschirurgie600